title: [Feasability and tolerance of adjuvant treatment of melanoma with immunotherapy according to Kirkwood protocol].
authors.forename: L
authors.initials: L
authors.lastname: Uwer
authors.forename: S
authors.initials: S
authors.lastname: Martin
authors.forename: L
authors.initials: L
authors.lastname: Geoffrois
authors.forename: J-L
authors.initials: JL
authors.lastname: Schmutz
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D011994:Recombinant Proteins; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins